“Dementia” is a syndrome, not one single disease. Alzheimer disease, vascular disease, Lewy body disease, frontotemporal degeneration and mixed pathologies can all produce cognitive decline.
Twin research reveals another complication: a genetic cause, a brain pathology and a clinical diagnosis are related, but they are not the same thing. Identical twins can match on one level and differ on another.
Quick answer
Can identical twins with the same dementia-related mutation or pathology still develop different disease courses?
Yes. Published twin cases show differences in age at onset and phenotype despite the same GRN mutation, while other identical twins had almost identical Lewy body pathology but different clinical diagnoses. These are small case-based data, but they clearly demonstrate biological and diagnostic variability.
Key takeaways
- Two identical twin women carrying the same pathogenic GRN mutation developed frontotemporal dementia five years apart.
- The twins also differed in some biomarkers, neuropsychological findings and smoking history, but one pair cannot establish what caused the timing difference.
- Another identical twin pair had virtually identical Lewy body pathology at autopsy but had been diagnosed differently during life — one with DLB and one with Alzheimer disease.
- In a 17-pair neuropathological twin study, four identical pairs with pure DLB in one twin remained discordant for dementia for up to 16 years or more.
- These reports show why genotype, neuropathology and clinical syndrome must be distinguished.
Frontotemporal dementia: same GRN mutation, five years apart
A 2019 case report described monozygotic twin sisters carrying the same Thr272fs mutation in GRN, a gene that can cause frontotemporal dementia. Both developed FTD, but one had onset at 68 and the other at 73.
They had the same formal education but differed in aspects of work, social activity, smoking, some cerebrospinal-fluid markers and cognitive testing. Those differences are scientifically interesting, but a single twin pair cannot identify which — if any — modified the age at onset.
Why FTD can look different from classic Alzheimer disease
Frontotemporal dementia often begins with changes in behaviour, personality, executive function or language rather than the memory-led presentation many people associate with Alzheimer disease.
Some FTD syndromes have a strong genetic component. That makes mutation-concordant identical twins with different timing especially informative: even a high-impact pathogenic variant does not necessarily determine an exact clinical calendar.
Lewy body disease: matching pathology, different labels
A reported monozygotic twin pair had virtually identical classic Lewy body pathology at postmortem examination. Yet during life, one twin had been diagnosed with dementia with Lewy bodies and the other with Alzheimer disease.
The case is a reminder that symptoms overlap. Fluctuating cognition, visual hallucinations, parkinsonism, falls and sleep-related features can point toward DLB, but clinical recognition is imperfect and mixed pathology is common in older adults.
Four identical pairs stayed discordant for dementia for years
A later Duke twin study examined 17 pairs in which at least one member had neuropathologically confirmed Lewy-body-related disease. Four monozygotic pairs had a proband with pure DLB; all four remained discordant for dementia for periods up to 16 years or more.
Among pairs with combined Alzheimer and Lewy body pathology, concordance for having dementia did not necessarily mean concordance for the same pathology. This suggests substantial room for modifiers beyond shared inherited DNA, although the sample was small.
Protein pathology is not a simple genetic readout
Neurodegenerative diseases often involve abnormal accumulation or handling of proteins. Genes can influence vulnerability, but age, inflammation, cellular stress, epigenetic regulation, other disease processes and stochastic events may influence when and where pathology crosses a clinical threshold.
Twin research cannot assign causality to those mechanisms by itself. What it does exceptionally well is expose the gap between a shared genetic starting point and a different clinical or pathological endpoint.
TwinPare perspective: the diagnosis is one layer of the story
FTD twins show that the same pathogenic mutation can produce different timing. Lewy body twins show that very similar pathology can produce different clinical labels — or that one twin can remain dementia-free while the other becomes ill.
That complexity is not a weakness in medicine. It is a reason to study disease at several levels at once: genes, molecules, pathology, symptoms, time and lived biology.
Source notes
The sources have been verified and editorially reviewed for this article. The limitations below show which level of conclusion the sources support.
- [fumagalli-2019] Monozygotic Twins with Frontotemporal Dementia Due To Thr272fs GRN Mutation Discordant for Age At Onset Giorgio Giulio Fumagalli et al.. Journal of Alzheimer’s Disease, 2019. Evidence type: Case report of monozygotic twin women carrying the same pathogenic GRN mutation Limitation: Both twins developed frontotemporal dementia, but onset differed by five years (68 versus 73). They also differed in some biomarkers, testing and smoking history; a single pair cannot establish why onset differed. PubMed DOI
- [santacruz-2002] Clinical presentations in monozygotic twins with dementia with Lewy bodies K S SantaCruz et al.. Journal of the American Medical Directors Association, 2002. Evidence type: Clinicopathological report of monozygotic twins Limitation: The twins had virtually identical Lewy body pathology at postmortem examination but received different clinical diagnoses during life — one DLB and one Alzheimer disease — illustrating diagnostic overlap. PubMed
- [wang-2009] Twin pairs discordant for neuropathologically confirmed Lewy body dementia C Sheei-Meei Wang et al.. Journal of Neurology, Neurosurgery & Psychiatry, 2009. Evidence type: Neuropathological twin study of 17 pairs Limitation: Four monozygotic pairs with a proband with pure DLB remained discordant for dementia for up to 16 years or more; mixed Alzheimer/Lewy pathology also differed within several pairs. PubMed PMC DOI
Editorial source review
This section shows how the article's key factual claims are linked to the source.
Phrasings that require caution
- These FTD and DLB examples rely on small twin case reports or small neuropathological samples.
- Do not infer that smoking, social activity or any single observed difference caused earlier or later disease in the GRN twins.
- Clinical dementia diagnosis and neuropathological diagnosis are related but not interchangeable.
| ID | Claim | Source support | Caution |
|---|